 |
|
Myasthenic CrisisResponse to Plasmapheresis Following Failure of Intravenous  -Globulin
Raphael B. Stricker, MD;
Beata J. Kwiatkowska, MD;
Joseph A. Habis, MD;
Dobri D. Kiprov, MD
Arch Neurol. 1993;50(8):837-840.
Abstract
• Myasthenic crisis is a potentially life-threatening complication of myasthenia gravis that requires aggressive therapy. We describe four patients in whom myasthenic crisis developed and who failed to respond to initial treatment with intravenous  -globulin. All four patients subsequently responded to intensive plasma exchange. Based on our experience, plasmapheresis appears to be superior to intravenous -globulin for the treatment of myasthenic crisis in certain patients. Prognostic factors that determine the effectiveness of intravenous -globulin vs plasmapheresis in these patients merit further investigation.
Author Affiliations
From the Division of Immunotherapy, Department of Medicine, California Pacific Medical Center (Drs Stricker, Kwiatkowska, and Kiprov), and the Department of Medicine, Kaiser Permanente Medical Center (Dr Habis), San Francisco.
Footnotes
Accepted for publication February 9, 1993.
Reprint requests to California Pacific Medical Center, California Campus, PO Box 7999, San Francisco, CA 94120 (Dr Stricker).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Noninvasive Ventilation in Myasthenic Crisis
Seneviratne et al.
Arch Neurol 2008;65:54-58.
ABSTRACT
| FULL TEXT
Intravenous Immunoglobulin Treatment in Neurologic Disorders: Yes
Sorensen
Arch Neurol 1999;56:1025-1027.
FULL TEXT
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?: No
Karussis and Abramsky
Arch Neurol 1999;56:1028-1032.
FULL TEXT
Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis
Qureshi et al.
Neurology 1999;52:629-629.
ABSTRACT
| FULL TEXT
|
